RBC Capital Upgrades Edwards Lifesciences (EW) to Top Pick, Price Target Offers 36% Upside

RBC Capital upgraded shares of Edwards Lifesciences (NYSE: EW) to a Top Pick rating from its previous rating of Outperform. The firm has also increased its price target from $90 to $92.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $67.60 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
• Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'
• Nomura/Instinet Upgrades Shimano (7309:JP) (SMNNY) to Buy